Arthritis Queensland Fellowship applications closing Friday 5pm 17 July 2015

The 2016 Arthritis Queensland Fellowship is a post-doctoral fellowship to support medical and clinical research into treatments for all forms of relevant musculoskeletal conditions and recognised symptoms arising from the conditions e.g. pain.

For more information visit the Arthritis Australia website or phone 02 9518 4441.

Read more about other research we support.

Guidelines

  1. The grant will be a stipend of $50,000 and is not renewable
  2. The recipient must be based in Queensland
  3. The recipient must be agreeable to developing a partnership with Arthritis Queensland (AQ) e.g. participate in relevant AQ marketing campaigns; be able and willing to communicate with AQ stakeholders.
  4. The recipient will provide periodic financial and performance reporting to AQ
  5. Ongoing recipient endorsement of AQ, especially in the event of significant progress in research.
  6. Within six months of completion of the fellowship, the recipient will be required to submit a written report in layman’s terms about the fellowship (for publication) as well as a full scientific report to Arthritis Australia and to Arthritis Queensland. Copies of any publications resulting from this work are also required.
  7. Acknowledgement of Arthritis Australia and Arthritis Queensland in all oral and written presentations/articles associated with the funding.

2015 Fellowship Recipient

The 2015 Arthritis Queensland Fellowship - $50,000 (funded by Arthritis Queensland) was awarded to Dr Karsten Schrobback Institute of Health and Biomedical Innovation, Queensland University of Technology Project: Biomarkers of mechanical stress and harmful loading on osteoarthritic knee cartilage

Osteoarthritis (OA) is an age-associated disease affecting 1.6 million Australians but there is no cure, due in large part to our lack of understanding of the disease. Abnormal biomechanical loading of cartilage tissue in the joint plays a major role in the development of knee osteoarthritis and is linked to important osteoarthritis risk factors, such as obesity, joint injury, malalignment and occupational overuse. This project will identify novel stress marker molecules released from knee cartilage in response to harmful tissue loading. These biomarkers will be validated in human body fluids taken from a cohort of older adults with and without knee osteoarthritis before and after controlled physical activity. The biomarkers will allow early detection of knee osteoarthritis and could be used to guide the design of patient-specific, physical exercises to increase joint health and defer costly knee replacement surgery. The project will also improve our holistic understanding of the impacts of mechanical load on cartilage.

Dr Karsten Schrobback is an early career researcher, who has completed his PhD in the area of cartilage matrix biology and regenerative medicine in 2010 at the Queensland University of Technology. He worked as a postdoctoral research fellow in the Cartilage Regeneration and Tissue Engineering group following his PhD, with Dr Tim Woodfield at the University of Otago, Christchurch (UOC), New Zealand. When his work in Christchurch was brought to a sudden end by the February earthquake in 2011, Dr Schrobback was able to continue his research projects in the Cartilage Regeneration Laboratory (CRL) of Assoc Prof Travis Klein at the Institute of Health and Biomedical Innovation (IHBI). He officially joined CRL in May 2011 and is the deputy leader of the group. Dr Schrobback has made significant contributions to the cartilage biology, osteoarthritis and tissue engineering literature through the publication of 11 peer-reviewed journal articles (4 as first author), 1 book chapter and over 23 conference abstracts).